You are here

Good EULAR Response In Patients With Early Rheumatoid Arthritis

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
G. Gennimatas General Hospital /Rheumatology Clinic
Athens, Attica, 11527 Greece
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Rheumatoid Arthritis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

1. signed and dated informed consent document

2. 18 years of age and older at the time of consent

3. Patients with moderate-to-severe active rheumatoid arthritis, who satisfy the 2010
Rheumatoid Arthritis Classification Criteria

4. Patients who have been prescribed for first time to receive treatment with MTX +
Etanercept prior to enrollment to this study, following routine clinical practice and
according to the approved SmPC,

5. Patients with DAS28 ≥ 3.2

6. Duration of disease symptoms ≥ 6 weeks and ≤2 years

7. Failure to respond to prior DMARDs including MTX monotherapy according to routine
clinical practice.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

1. Contraindications according to the SmPC

2. History of or present anti-TNFa or other biologic therapy for the treatment of RA

3. Known significant concurrent medical disease according to investigator's opinion and
the current SmPC

NCT01558089
Pfizer
Completed
Good EULAR Response In Patients With Early Rheumatoid Arthritis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Rheumatoid Arthritis
NCT03981900
All Genders
18+
Years
Multiple Sites
Rheumatoid Arthritis
NCT03992781
All Genders
Crohn Desease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
NCT02925338
All Genders
6+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now